• Katarzyna Fijał and Małgorzata Filip.
• *Laboratory of Drug Addiction Pharmacology, Institute of Pharmacology, Polish Academy of Sciences; and †Faculty of Pharmacy, College of Medicine, Jagiellonian University, Kraków, Poland.
• Clin Neuropharmacol. 2016 Mar 1; 39 (2): 94-101.

ObjectiveCannabinoids, the components of Cannabis sativa Linnaeus, interact with CB1 and CB2 receptors, which are located both in the central nervous system and in the periphery and thus may exert a widespread biological activity in the body. The main medicinal properties of cannabinoids include analgesic, anti-inflammatory, antitumor, appetite stimulation, antiemesis, and muscle relaxation effects. This mini review aims to explore existing clinical trials that investigated the use of cannabinoids in diseases affecting the nervous system.MethodsWe reviewed recent studies of cannabinoid-based therapy for disorders affecting central and peripheral nervous system in human subjects.ResultsThere is evidence that cannabinoid-based drugs may effectively control some symptoms associated with nervous system dysfunction, especially various types of pain and neurologic disorders, although studies are limited.ConclusionsThe efficacy of cannabinoid drugs in the treatment of nervous system diseases should be verified in future large-scale randomized clinical trials.

8 keywords...

hide…